Temporal‐Parotid Resection for Malignant Parotid Tumors: A Systematic Review
The Laryngoscope · 2025-11 · 135 (11) · 4009-4019
DOI: 10.1002/lary.32267 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Laryngoscope, online erschienen am 14.05.2025. Verfasst von Antonio Daloiso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Otorhinolaryngology - Head and Neck Surgery, Department of Neuroscience, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Parotid Neoplasms, Parotid Gland, Temporal Bone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Surgery involving the skull base has recently gained significant prominence in treatment of head and neck cancer. “En bloc temporal‐parotid resection,” as applied in primary malignancies of the external ear, should be considered as a shift in the surgical landscape of “extended total parotidectomies” to achieve negative surgical margins and decrease the risk of tumor spillage during the procedure. The purpose of this systematic review is to evaluate survival outcomes and margin status in patients with parotid malignancies involving the temporal bone and treated with temporal‐parotid resection (TPR). Data Sources PubMed, Scopus, and Embase databases were systematically searched until 11 February 2025. Review Methods The protocol of this investigation was registered on PROSPERO in February 2024 and the systematic review was performed according to the PRISMA method.
Results
The study included 336 patients from 13 articles published between 1993 and 2019. Negative surgical margins were achieved in 74.5% of cases. After a median follow‐up of 32 months, 64.0% of patients achieved local disease control. Most patients (51.4%) experienced distant metastases during follow‐up. Three‐year overall survival (OS) and disease‐specific survival (DSS) ranged between 72.4%–57.1% and 79.0%–66.7%, respectively.
Conclusion
TPR represents a viable strategy to achieve safe oncological margins and adequate local disease control in patients with parotid gland malignancies infiltrating or abutting the temporal bone. Our findings support the growing interest in TPR, highlighting the need for further studies to refine patient selection criteria, surgical techniques, and postoperative management strategies. Trial Registration: PROSPERO: CRD42024512013 Level of Evidence NA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Otorhinolaryngology - Head and Neck Surgery, Department of Neuroscience, University of Padova, Padova, Italy.
- Unit of Otorhinolaryngology - Head and Neck Surgery, Padua University Hospital, Padova, Italy.
- Unit of Phoniatrics and Audiology, Ospedale Ca' Foncello Treviso - ULSS 2 Marca Trevigiana, Department of Neurosciences, University of Padova, Treviso, Italy.
ORCID-Profile: Antonio Daloiso, Diego Cazzador, Leonardo Franz, Piero Nicolai, Elisabetta Zanoletti
Zitieren
APA
Daloiso, A., Cazzador, D., Tealdo, G., Martini, G., Franz, L., Mazzoni, A., Nicolai, P., & Zanoletti, E. (2025). Temporal‐Parotid Resection for Malignant Parotid Tumors: A Systematic Review. The Laryngoscope, 135(11), 4009-4019. https://doi.org/10.1002/lary.32267
Vancouver
Daloiso A, Cazzador D, Tealdo G, Martini G, Franz L, Mazzoni A, et al. Temporal‐Parotid Resection for Malignant Parotid Tumors: A Systematic Review. The Laryngoscope. 2025;135(11):4009-4019. doi:10.1002/lary.32267
BibTeX
@article{Daloiso2025,
author = {Daloiso, Antonio and Cazzador, Diego and Tealdo, Giulia and Martini, Gioia and Franz, Leonardo and Mazzoni, Antonio and Nicolai, Piero and Zanoletti, Elisabetta},
title = {Temporal‐Parotid Resection for Malignant Parotid Tumors: A Systematic Review},
journal = {The Laryngoscope},
year = {2025},
volume = {135},
number = {11},
pages = {4009--4019},
doi = {10.1002/lary.32267}
}
EUVIMED